List of Veeva Crossix DIFA Customers
Veeva Systems
4280 Hacienda Drive,
Pleasanton, 94588, CA,
United States
Pleasanton, 94588, CA,
United States
1 925-452-6500
Professional Services
7291
$3.1B
Since 2010, our global team of researchers has been studying Veeva Crossix DIFA customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Veeva Crossix DIFA for Marketing Analytics from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Veeva Crossix DIFA for Marketing Analytics include: Johnson & Johnson, a United States based Life Sciences organisation with 138100 employees and revenues of $88.82 billion, GSK, a United Kingdom based Life Sciences organisation with 69310 employees and revenues of $42.21 billion, Amgen, a United States based Life Sciences organisation with 28000 employees and revenues of $33.42 billion, Gilead Sciences, a United States based Life Sciences organisation with 17600 employees and revenues of $28.75 billion, Starcom Mediavest Group, Inc., a United States based Professional Services organisation with 3000 employees and revenues of $615.0 million and many others.
Contact us if you need a completed and verified list of companies using Veeva Crossix DIFA, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Veeva Crossix DIFA customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Amgen | Life Sciences | 28000 | $33.4B | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2017 | n/a |
In 2017, Amgen implemented Veeva Crossix DIFA to centralize Marketing Analytics for its commercial brand and media measurement workflows. Veeva Crossix DIFA was deployed as a Marketing Analytics application to provide privacy-focused audience measurement and campaign analytics support for Amgen’s marketing and analytics teams.
The implementation emphasized core Marketing Analytics capabilities, including audience segmentation, cross-channel measurement, campaign attribution workflows, and healthcare-compliant handling of de-identified patient information. Veeva Crossix DIFA was configured to ingest and normalize marketing and media signal data, and to produce analytic outputs that support planning and measurement use cases typical of pharmaceutical brand teams.
Operational coverage targeted Amgen’s commercial marketing, media planning, and analytics functions, aligning measurement outputs with brand planning and media buy decision processes. The deployment incorporated data governance controls and privacy-first processes to ensure compliance with health data expectations, and the program included role-based access and structured reporting for marketing stakeholders.
Governance and rollout focused on embedding the Marketing Analytics capability into existing campaign planning workflows, updating measurement governance, and equipping brand and analytics staff with new operational procedures for media measurement and audience insights. The implementation narrative centers on Veeva Crossix DIFA as the marketing analytics engine used to standardize healthcare audience measurement within Amgen’s commercial organization.
|
 |
Dotdash, Inc. | Professional Services | 100 | $30M | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2018 | n/a |
In 2018, Dotdash, Inc. implemented Veeva Crossix DIFA as a central component of its Marketing Analytics capabilities. Veeva Crossix DIFA was deployed to deliver pre to post sale insights for pharmaceutical accounts and to support revenue driven account strategies for major pharma clients including Novartis, GSK and AbbVie.
The implementation emphasized campaign measurement, audience attribution, and health care audience linkage capabilities consistent with Marketing Analytics platforms. Configuration work produced campaign level reporting, custom performance decks, and analyst workflows that ingested Crossix DIFA outputs for seller enablement and campaign optimization. Teams used Veeva Crossix DIFA to surface audiences and attribution signals that informed creative targeting and media placement decisions.
Integrations were operationalized with DoubleVerify, Google Analytics, MOAT, and proprietary data tools to consolidate viewability, site analytics, and ad verification metrics alongside Crossix DIFA's audience signals. The deployment operated cross functionally across marketing, editorial, digital production, analytics, research, product, ad ops, finance, development, offshore client success, and sales teams. Operational usage included direct analyst access for campaign analysis and shared reporting used in client facing presentations.
Governance and rollout were led through account strategy and onboarding routines, with staff training and peer mentoring part of the operating model. The account lead maintained 14 accounts as the seller and account strategist for five months in 2018, managed a 7.5 million dollar book of business for major pharma clients, and led product training for new sales and marketing team members. Reported outcomes include incremental revenue captured in 2019 in excess of 1 million dollars to date and a quarterly performance movement from 101 percent to 113 percent by capturing an incremental 150 thousand dollars.
|
 |
Gilead Sciences | Life Sciences | 17600 | $28.8B | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2017 | n/a |
In 2017, Gilead Sciences implemented Veeva Crossix DIFA as a Marketing Analytics platform. The rollout established Veeva Crossix DIFA as a cloud-hosted analytics layer focused on healthcare and life sciences measurement, supporting brand and commercial analytics use cases within the organization.
The implementation emphasized core Marketing Analytics capabilities including deterministic identity resolution, audience segmentation, media measurement, and campaign attribution, with the Veeva Crossix DIFA application providing the analytics and modelling engines for these functions. Reporting and visualization capabilities were configured to support campaign-level and audience-level analysis, enabling standardized marketing measurement workflows.
Operational integration centered on embedding Veeva Crossix DIFA into marketing and commercial analytics processes, with data ingestion pipelines feeding deidentified healthcare signals into the platform and outputs routed to activation and reporting workflows. The architecture positioned Veeva Crossix DIFA as a centralized analytics service that interfaced with internal marketing systems and media channels through data exchange and standardized exports.
Governance and process changes accompanied the deployment, instituting privacy controls and data stewardship practices to manage healthcare-sensitive data within marketing operations. Veeva Crossix DIFA was used to operationalize measurement governance, formalize campaign measurement processes, and consolidate cross-channel audience analytics for Gilead Sciences.
|
 |
GSK | Life Sciences | 69310 | $42.2B | United Kingdom | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2021 | n/a |
In 2021, GSK implemented Veeva Crossix DIFA for Marketing Analytics to strengthen privacy‑safe audience measurement within its commercial analytics stack. The deployment was executed inside an existing Veeva portfolio that includes Vault CDMS, Vault Clinical Operations Suite, Vault Quality Suite, Vault Registrations, Vault Submissions, Vault Submissions Archive, Veeva CRM, Veeva Align, Veeva Crossix, Vault PromoMats, Veeva OpenData, and Vault MedComms, positioning Veeva Crossix DIFA as the Marketing Analytics engine for campaign measurement and audience insight.
Veeva Crossix DIFA was configured to deliver de‑identified identity resolution, cross‑channel audience segmentation, and media measurement capabilities, supporting campaign attribution, reach and frequency reporting, and audience lift analysis typical of Marketing Analytics platforms. Functional configuration focused on privacy‑compliant data processing pipelines and analytics modules that produce de‑identified audience models and campaign performance dashboards for commercial marketing teams.
Operational coverage centered on integrating Crossix DIFA analytics into commercial reporting and planning workflows alongside Veeva CRM and Vault PromoMats, enabling marketing, media planning, and commercial operations to consume standardized measurement outputs. Governance emphasized pharmaceutical privacy and compliance controls, with role‑based access and data governance workflows to manage de‑identified datasets and measurement processes across GSK’s commercial analytics organization.
|
 |
Healthy Offers, Inc | Professional Services | 100 | $15M | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2018 | n/a |
In 2018 Healthy Offers, Inc implemented Veeva Crossix DIFA, a Marketing Analytics application from Veeva Systems. The deployment supported the company's account management and media trading workflows across its United States operations, and was scoped to manage priority accounts representing over $5MM in media while measuring performance for more than 10 campaigns annually.
Veeva Crossix DIFA was configured to deliver audience measurement, attribution, campaign-level reporting, and cross-channel measurement workflows, with explicit support for addressable TV measurement use cases. The configuration included dashboarding and pacing controls to enable campaign optimization, automated pacing alerts, and client-facing semi-monthly performance reports used to drive adjustments across awareness, click-through rate, on-site engagement, and coupon download KPIs.
The implementation integrated Veeva Crossix DIFA with third-party verification and measurement tools including IAS, Double Verify, Comscore, IQ Via, and Moat, consolidating viewability, verification, and measurement signals into the Marketing Analytics layer. Crossix DIFA functioned as the healthcare-focused measurement engine while verification vendor feeds informed trading optimizations, tying analytics outputs directly to account management, trading, and finance workflows for reporting and billing.
Governance and operational cadence were formalized with weekly internal performance check-ins, semi-monthly performance and pacing reports to clients, end-of-month billing processes, and a single client point of contact responsible for priority accounts and closing incremental upsells. The engagement included structured training and onboarding for new account management hires, and the platform lead served as the subject matter expert on new technology opportunities including addressable TV, centralizing measurement, reporting, and client escalation within the Marketing Analytics stack.
|
 |
|
Professional Services | 1000 | $120M | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2016 | n/a |
|
|
|
|
Life Sciences | 138100 | $88.8B | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2017 | n/a |
|
|
|
|
Professional Services | 13000 | $300M | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2017 | n/a |
|
|
|
|
Professional Services | 3000 | $615M | United States | Veeva Systems | Veeva Crossix DIFA | Marketing Analytics | 2017 | n/a |
|
Showing 1 to 9 of 9 entries
Buyer Intent: Companies Evaluating Veeva Crossix DIFA
ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Veeva Crossix DIFA. Gain ongoing access to real-time prospects and uncover hidden opportunities. Companies Actively Evaluating Veeva Crossix DIFA for Marketing Analytics include:
- Tripadvisor, a United States based Professional Services organization with 2850 Employees
- Millennium, a United States based Banking and Financial Services company with 6100 Employees
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated |
|---|---|---|---|---|---|---|
 |
Tripadvisor | Professional Services | 2850 | $1.8B | United States | 2025-08-20 |
 |
Millennium | Banking and Financial Services | 6100 | $3.0B | United States | 2025-06-10 |
FAQ - APPS RUN THE WORLD Veeva Crossix DIFA Coverage
Veeva Crossix DIFA is a Marketing Analytics solution from Veeva Systems.
Companies worldwide use Veeva Crossix DIFA, from small firms to large enterprises across 21+ industries.
Organizations such as Johnson & Johnson, GSK, Amgen, Gilead Sciences and Starcom Mediavest Group, Inc. are recorded users of
Veeva Crossix DIFA for Marketing Analytics.
Companies using Veeva Crossix DIFA are most concentrated in Life Sciences and Professional Services, with adoption spanning over 21 industries.
Companies using Veeva Crossix DIFA are most concentrated in United States and United Kingdom, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Veeva Crossix DIFA across Americas, EMEA, and APAC.
Companies using Veeva Crossix DIFA range from small businesses with 0-100 employees - 22.22%, to mid-sized firms with 101-1,000 employees - 11.11%, large organizations with 1,001-10,000 employees - 11.11%, and global enterprises with 10,000+ employees - 55.56%.
Customers of Veeva Crossix DIFA include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.
Contact APPS RUN THE WORLD to access the full verified Veeva Crossix DIFA customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Marketing Analytics.